Retrieve available abstracts of 8 articles: HTML format
Single Articles
April 2025
RADIC L, Offersgaard A, Kadava T, Zon I, et al Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein.
Proc Natl Acad Sci U S A. 2025;122:e2420402122. PubMedAbstract available
March 2025
SARWAR S, Randall G HCV NS3/4A protease relocalizes CCTalpha to viral replication sites, enhancing
phosphatidylcholine synthesis and viral replication.
Proc Natl Acad Sci U S A. 2025;122:e2419632122. PubMedAbstract available
June 2024
HAMMEL A, Cucos LM, Caras I, Ionescu I, et al The red alga Porphyridium as a host for molecular farming: Efficient production
of immunologically active hepatitis C virus glycoprotein.
Proc Natl Acad Sci U S A. 2024;121:e2400145121. PubMedAbstract available
April 2024
PAPINI C, Ullah I, Ranjan AP, Zhang S, et al Proof-of-concept studies with a computationally designed M(pro) inhibitor as a
synergistic combination regimen alternative to Paxlovid.
Proc Natl Acad Sci U S A. 2024;121:e2320713121. PubMedAbstract available
February 2024
KOONIN EV Circular RNAs from linear viral RNA genomes: A distinct dimension in the virus
world.
Proc Natl Acad Sci U S A. 2024;121:e2401335121. PubMed
CAO QM, Boonchuen P, Chen TC, Lei S, et al Virus-derived circular RNAs populate hepatitis C virus-infected cells.
Proc Natl Acad Sci U S A. 2024;121:e2313002121. PubMedAbstract available
June 2023
MOSA AI, Campo DS, Khudyakov Y, AbouHaidar MG, et al Polyvalent immunization elicits a synergistic broadly neutralizing immune
response to hypervariable region 1 variants of hepatitis C virus.
Proc Natl Acad Sci U S A. 2023;120:e2220294120. PubMedAbstract available
March 2021
RASCHE A, Lehmann F, Goldmann N, Nagel M, et al A hepatitis B virus causes chronic infections in equids worldwide.
Proc Natl Acad Sci U S A. 2021;118:e2013982118. PubMedAbstract available